These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 21559457)
41. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117 [TBL] [Abstract][Full Text] [Related]
42. Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma. Suares A; Mori Sequeiros Garcia M; Paz C; González-Pardo V Cell Signal; 2017 Apr; 32():124-132. PubMed ID: 28161489 [TBL] [Abstract][Full Text] [Related]
43. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510 [TBL] [Abstract][Full Text] [Related]
46. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111 [TBL] [Abstract][Full Text] [Related]
47. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190 [TBL] [Abstract][Full Text] [Related]
48. A major role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes. Sapochnik D; Raimondi AR; Medina V; Naipauer J; Mesri EA; Coso O Front Oncol; 2022; 12():890825. PubMed ID: 36212441 [TBL] [Abstract][Full Text] [Related]
49. Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. Liu G; Yu FX; Kim YC; Meng Z; Naipauer J; Looney DJ; Liu X; Gutkind JS; Mesri EA; Guan KL Oncogene; 2015 Jul; 34(27):3536-46. PubMed ID: 25195862 [TBL] [Abstract][Full Text] [Related]
50. Kaposi's sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway. Angelova M; Ferris M; Swan KF; McFerrin HE; Pridjian G; Morris CA; Sullivan DE Virol J; 2014 Dec; 11():218. PubMed ID: 25514828 [TBL] [Abstract][Full Text] [Related]
51. Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells. Shin JM; Jeong YJ; Cho HJ; Park KK; Chung IK; Lee IK; Kwak JY; Chang HW; Kim CH; Moon SK; Kim WJ; Choi YH; Chang YC PLoS One; 2013; 8(7):e69380. PubMed ID: 23936001 [TBL] [Abstract][Full Text] [Related]
53. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. Pati S; Foulke JS; Barabitskaya O; Kim J; Nair BC; Hone D; Smart J; Feldman RA; Reitz M J Virol; 2003 May; 77(10):5759-73. PubMed ID: 12719569 [TBL] [Abstract][Full Text] [Related]
54. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor. Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989 [TBL] [Abstract][Full Text] [Related]
55. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science. Dezube BJ; Sullivan R; Koon HB J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705 [TBL] [Abstract][Full Text] [Related]
56. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. Yang TY; Chen SC; Leach MW; Manfra D; Homey B; Wiekowski M; Sullivan L; Jenh CH; Narula SK; Chensue SW; Lira SA J Exp Med; 2000 Feb; 191(3):445-54. PubMed ID: 10662790 [TBL] [Abstract][Full Text] [Related]
57. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways. Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084 [TBL] [Abstract][Full Text] [Related]
58. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor. Aguilar B; Choi I; Choi D; Chung HK; Lee S; Yoo J; Lee YS; Maeng YS; Lee HN; Park E; Kim KE; Kim NY; Baik JM; Jung JU; Koh CJ; Hong YK Cancer Res; 2012 Nov; 72(22):5833-42. PubMed ID: 22942256 [TBL] [Abstract][Full Text] [Related]
59. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3. Rivera-Soto R; Dissinger NJ; Damania B J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855 [TBL] [Abstract][Full Text] [Related]
60. A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Chang HH; Ganem D Cell Host Microbe; 2013 Apr; 13(4):429-40. PubMed ID: 23601105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]